The Effect of Gefitinib on Treatment Necessity and Prognosis of NSCLC Patients with Early EGFR Mutations

OBJECTIVE: To investigate the need for and prognostic impact of gefitinib on the treatment of patients with early-stage epidermal growth factor receptor (EGFR) mutated non-small-cell lung cancer (NSCLC). METHODS: Clinical data of patients with stage IB-IIA non-squamous non-small-cell lung cancer adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Ruiqiang, Cheng, Yanbo, Zheng, Tianxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578812/
https://www.ncbi.nlm.nih.gov/pubmed/36304772
http://dx.doi.org/10.1155/2022/2228744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578812/
https://www.ncbi.nlm.nih.gov/pubmed/36304772
http://dx.doi.org/10.1155/2022/2228744

Ejemplares similares